By Aaron Leibowitz ( November 6, 2018, 4:16 PM EST) -- The former chief financial officer for Aveo Pharmaceuticals "hid" from investors that a government agency had recommended a new clinical trial for the company's prize kidney cancer drug, an attorney for the U.S. Securities and Exchange Commission told a jury Tuesday in Boston federal court....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.